TABLE 3.
Promote studies comparing CWD technology with gold-standard reference devices in diverse cohorts of patients and environmental conditions.5,72,99 |
Assess the safety and outcomes of CWDs for telemonitoring in patients with established forms of cardiovascular disease.108,109 |
Optimize and study the accuracy of CWD technology in the measurement of health metrics during exercise (eg, exercise-induced arrhythmias).110 |
Assess how intraindividual alterations in CWD-derived health metrics affect outcomes in those with and without cardiovascular disease. |
Study the effect of artificial intelligence on health metric measurement and interpretation.109 |
Involve HCPs in CWD design and implementation to ensure clinically relevant health metrics and data reporting.2,109 |
Prioritize data security for patients and accessibility to CWD data for HCPs in electronic health records.2,6 |
Promote transparency surrounding medico-legal liability for HCPs being sent and interpreting data from CWDs.6,44 |
Ensure equitable distribution of CWDs with consideration of incentives to alleviate costs for CWDs following medical approval.44,111 |
Promote equitable compensation for HCPs in the interpretation of data from CWDs.111,112 |
Develop ongoing CME for providers on interpretation of current and emerging CWD technology and to design and study the effect of educational tools to promote digital health literacy.6,44,109 |
CME = continuing medical education; CWD = consumer wearable device; HCP = health care provider.